Pre-clinical evaluation of a potent and effective Pin1-degrading agent in pancreatic cancer
{{output}}
The peptidyl-prolyl isomerase protein Pin1 has been shown to contribute to cancer onset, development, and progression by regulating the function and stability of oncogenes and tumor suppressors, both in cancer cells and surrounding stromal cells. Hence, it has... ...
